Mosaic ImmunoEngineering Inc. (CPMV) stock
CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.33+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Mosaic ImmunoEngineering cash
Cash and short-term investments held at the end of each period.
Mosaic ImmunoEngineering's cash was $26 at Jun 30, 2026. For fiscal 2025 it was $3.62K, down 96.9% from the year before. Over ten years it grew -52.7% a year on average. The highest annual figure on record is $10.66M in fiscal 2011.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.62K | -96.9% |
| FY2024 | Dec 31, 2024 | $115.02K | -26.4% |
| FY2023 | Dec 31, 2023 | $156.18K | -29.2% |
| FY2022 | Dec 31, 2022 | $220.65K | +44029.0% |
| FY2020 | May 31, 2020 | $500 | -100.0% |
| FY2019 | May 31, 2019 | $1.54M | -33.7% |
| FY2018 | May 31, 2018 | $2.32M | -27.6% |
| FY2017 | May 31, 2017 | $3.20M | +2.9% |
| FY2016 | May 31, 2016 | $3.12M | -39.3% |
| FY2015 | May 31, 2015 | $5.13M | -20.0% |
| FY2014 | May 31, 2014 | $6.42M | -17.4% |
| FY2013 | May 31, 2013 | $7.77M | +2.1% |
| FY2012 | May 31, 2012 | $7.61M | -28.7% |
| FY2011 | May 31, 2011 | $10.66M | +3.1% |
| FY2010 | May 31, 2010 | $10.34M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $26 | -100.0% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $72 | -99.9% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $3.62K | -96.9% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $31.76K | +453.7% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $53.58K | +1335.0% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $85.93K | +32.1% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $115.02K | -26.4% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $5.74K | -97.7% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $3.73K | -99.0% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $65.04K | -48.3% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $156.18K | -29.2% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $252.90K | -34.2% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $362.97K | +76.2% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $125.78K | -66.7% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $220.65K | +44029.0% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $384.14K | -48.7% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $205.99K | -78.6% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $378.06K | -69.5% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $500 | -100.0% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | $748.83K | -57.6% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $963.00K | -48.6% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | $1.24M | -39.2% |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $1.54M | -33.7% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $1.77M | -29.7% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $1.87M | -30.7% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | $2.04M | -31.0% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $2.32M | -27.6% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $2.51M | -24.3% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $2.70M | -18.2% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $2.95M | +9.7% |
| Q4 FY2017CQ2 2017 | May 31, 2017 | $3.20M | +2.9% |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $3.32M | -10.9% |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $3.30M | -19.1% |
| Q1 FY2017CQ3 2016 | Aug 31, 2016 | $2.69M | -41.4% |
| Q4 FY2016CQ2 2016 | May 31, 2016 | $3.12M | -39.3% |
| Q3 FY2016CQ1 2016 | Feb 29, 2016 | $3.72M | -31.9% |
| Q2 FY2016CQ4 2015 | Nov 30, 2015 | $4.08M | – |
| Q1 FY2016CQ3 2015 | Aug 31, 2015 | $4.60M | – |
| Q4 FY2015CQ2 2015 | May 31, 2015 | $5.13M | – |
| Q3 FY2015CQ1 2015 | Feb 28, 2015 | $5.47M | – |
See a number that looks wrong?